Table 3 New People (first year in clinic) vs Existing People (from previous years) (BMI ≥ 35 kg/m²)

Age

54.2 ± 14.9

61.0 ± 12.4

%Women

51% (n = 107)

56% (n = 116)

Weight (kg)

120.6 ± 24.8

118.4 ± 21.4

BMI (kg/m²)

42.4 ± 7.2

42.8 ± 6.5

Duration of Diabetes (years)

10.0 ± 9.0

13.5 ± 8.6

Starting HbA1c ^a

78 ± 27 mmol/mol (9.3 ± 2.5%)

66 ± 21 mmol/mol (8.2 ± 1.9%)

HbA1c reduction (%) ^a

18 ± 31 mmol/mol (1.6 ± 2.8%)

3 ± 16 mmol/mol (0.3 ± 1.4%)

% achieving HbA1c < 53 mmol/mol (7.0%) ^a

31%

23%

% with HbA1c > 75 mmol/mol (9.0%) ^a

33%

22%

% on Insulin

59% (n = 123)

70% (n = 144)

Metformin

83% (n = 173)

75% (n = 156)

Sulphonylurea

27% (n = 56)

41% (n = 85)

DPP4i

25% (n = 51)

24% (n = 49)

GLP1 agonist

18% (n = 37)

20% (n = 41)

SGLT2i

23% (n = 48)

32% (n = 65)

Endocrinologist Appointments Attended/patient

1.8 ± 1.8

1.8 ± 0.9

Total Diabetes Specialist Nurse (Educator) Appointments Attended/patient

0.8 ± 1.5

0.4 ± 0.9

Total Dietician Appointments Attended/patient

0.4 ± 0.7

0.2 ± 0.5